Andrew C. Karlinski’s First Horizon FHN Stock Holding History

Andrew C. Karlinski’s Portfolio FHN Stock Details FHN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-150	Closed	-$3K	–	73
2022 Q3	$3K	Sell	150 -28	-16%	-$636	﹤0.01%	205
2022 Q2	$4K	Buy	178 +1	+0.6%	+$22	0.01%	212
2022 Q1	$4K	Sell	177 -22	-11%	-$439	0.01%	216
2021 Q4	$3K	Buy	+199	New	+$3.32K	0.01%	168

Other funds holding FHN

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

SFM

Soros Fund Management New York $9.12B AUM 30.69% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Andrew C. Karlinski's FHN Position: Q4 2022 in Review

Andrew C. Karlinski sold out of First Horizon (FHN) in Q4 2022, closing a stake of 150 shares — an estimated $3K sold.

Andrew C. Karlinski first reported a position in FHN in Q4 2021 and held it in 4 quarters. The position peaked at $4K in Q2 2022. 613 funds tracked by Wall St. Rank hold FHN as of Q4 2022.

Andrew C. Karlinski reported no remaining First Horizon position as of Q4 2022 after selling out during the quarter.
Andrew C. Karlinski sold 150 First Horizon shares in Q4 2022, an estimated $3K.
Andrew C. Karlinski first reported a position in First Horizon in Q4 2021 and held it in 4 quarters.
Andrew C. Karlinski's First Horizon position peaked at $4K in Q2 2022.
613 funds tracked by Wall St. Rank held First Horizon as of Q4 2022.

Based on Andrew C. Karlinski's 13F filing for Q4 2022.